Nordic Cell Therapy Group is a specialized platform advancing the development of cell-based therapies through integrated expertise in consulting, analytics, and therapeutic development.

We collaborate with innovators, biotech and pharmaceutical companies, and academic teams to accelerate the translation of regenerative medicine — combining scientific depth, development experience, and strategic insight to move therapies closer to patients.

Our activities are structured across three complementary divisions:

• Consulting. Specialized scientific and strategic expertise across the full development lifecycle, from discovery to clinical and commercial readiness
• Analytics. Advanced analytical solutions, including off-the-shelf and custom assay development to support process understanding and manufacturing
• Ventures. Internal development programs focused on next-generation cell therapies, currently in ophthalmology and vision restoration

Our team brings decades of experience across the entire value chain of cell therapy development, including pluripotent stem cell biology, process development, GMP manufacturing, analytical strategy, and regulatory planning.

Across all activities, we focus on enabling robust, scalable, and clinically relevant development strategies, reducing risk, improving efficiency, and accelerating progress toward patients.

Nordic Cell Therapy Group bridges science, analytics, and development to support partners and advance the next generation of cell therapies.

Nordic Cell Therapy Group

Org chart

Teams

Offices